|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Ministry of Health, Rwanda |
|---|---|
| Collaborator: |
Ministry of Defence, Rwanda |
| Information provided by: | Ministry of Health, Rwanda |
| ClinicalTrials.gov Identifier: | NCT01150370 |
Purpose
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda
| Condition | Intervention |
|---|---|
|
Male Circumcision HIV Prevention HIV Infections |
Device: The PrePex a novel device for adult male circumcision |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings |
Outcome measures will include:
Number of Participants with Adverse Events as a Measure of Safety,
Pain as measured by Visual Analogue Scale (VAS),
Wound healing rate.
Outome measure include:
Duration required by diffrent personnel to perform the procedure Procedure performance by nurses
Outcome measure include:
Quality of life and satisfaction questionnaire
Outcome measure includes:
Physicians questionnaire on the clinical and practical performance of the procedure
Outcome measure include:
Weekly follow up visits post procedure, compliance with post procedure instructions questionnaire
| Estimated Enrollment: | 50 |
| Study Start Date: | June 2010 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Males undergoing circumcision |
Device: The PrePex a novel device for adult male circumcision
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs. The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, without the need for sterile, hospital settings.
|
Multiple randomized and controlled studies (WHO, USAID, UNAIDS) have proven that circumcised men in high risk areas reduce their risk of HIV infection by 60%.
The Government of Rwanda has ranked HIV prevention as a top priority item, and wishes to decrease the HIV incidence in the country by 50%. As part of a holistic HIV prevention approach, we decided to embark upon a process of national scale up of adult male circumcision. The national HIV prevention plan calls for voluntary MC of 2 million adults by the end of 2012.
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs, to support global public health efforts to stop the spread of HIV.
The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, in urban or rural settings, without the need for sterile, hospital settings. As such, The PrePex System places minimal burden on the existing health care infrastructure to accomplish national circumcision programs.
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda.
Eligibility| Ages Eligible for Study: | 18 Years to 54 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Rwanda | |
| Kanombe Military Hospital | |
| Kigali, Rwanda, 3377 | |
| Principal Investigator: | Dr. Jean Paul Bitega, M.D. | Kanombe Military Hospital |
More Information
| Responsible Party: | Ministry of Health, Rwanda |
| ClinicalTrials.gov Identifier: | NCT01150370 History of Changes |
| Other Study ID Numbers: | CMT-01 |
| Study First Received: | June 23, 2010 |
| Last Updated: | January 10, 2011 |
| Health Authority: | Rwanda: Ministry of health |
|
male circumcision HIV Rwanda HIV Seronegativity |
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |